Please enable JavaScript to use this page!

Certican® relaunch

Client

Novartis

Therapeutical Area

Transplantation

Brief

[:en]Everolimus is the 40-O-(2-hydroxyethyl) derivative of sirolimus and works as an inhibitor of mammalian target of rapamycin (mTOR). It is currently used as an immunosuppresant to prevent rejection of organ transplants. Certican® a heavyweight in the defense of life. Lungs, heart, kidneys, liver work hard in the battle for life. Campaign won best Integrated campaign to physician.[:es]undefinedundefinedundefinedundefinedundefinedundefinedundefined

En trasplante de órganos, la principal prioridad de los médicos es evitar el rechazo. Certican es un peso pesado de los tratamientos inmunosupresores.[:]

We did

Creativity // Medical Writing // Audiovisual // Digital // Events

novartis-logo